Latest Monoclonal antibodies Stories
NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK(TM) Products and the Checkpoint Inhibitors PD-1 and PD-L1 SAN DIEGO, Mar.
If authorized, SB2 will be marketed in Europe by Biogen Idec INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization
DALLAS, March 13, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Hidradenitis Suppurativa - Pipeline Review, H1 2015" therapeutic market research report provides an overview
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014.
TAMPA, Fla., March 12, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.
AUSTIN, Texas, March 4, 2015 /PRNewswire/ -- XBiotech announced today that results from its Phase II pilot study in patients with moderate to severe plaque psoriasis have been published in JAMA
Tools to support preclinical research, drug development and validation Santa Clara, California (PRWEB) March 03, 2015 Crown Bioscience, Inc., a leading
- Potentially first biomarker-guided schizophrenia therapeutic SAN DIEGO, March 3, 2015 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has exclusively licensed
QUEBEC CITY, Feb.
- The parings of haberdine; also, any kind of fragments.
More Images (1 images) »